(Q37678995)

21 August 2017

1 reference

title

Drugs targeting Toll-like receptors (English)

1 reference

21 August 2017

0 references

Jayalakshmi Krishnan

1

1 reference

PubMed ID

20091261

21 August 2017

Gwang Lee

series ordinal

2

1 reference

PubMed ID

20091261

21 August 2017

Sangdun Choi

series ordinal

3

1 reference

21 August 2017

1 November 2009

1 reference

Archives of Pharmacal Research

21 August 2017

1 reference

21 August 2017

32

1 reference

21 August 2017

1485-1502

1 reference

21 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1007/s12272-009-2100-6

21 August 2017

0 references

cites work

Activation of innate immunity, inflammation, and potentiation of DNA vaccination through mammalian expression of the TLR5 agonist flagellin.

1 reference

https://api.crossref.org/works/10.1007%2FS12272-009-2100-6

The nuclear IkappaB protein IkappaBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-009-2100-6

Cutting edge: naturally occurring soluble form of mouse Toll-like receptor 4 inhibits lipopolysaccharide signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-009-2100-6

Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-009-2100-6

Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-009-2100-6

Toll-like receptor signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-009-2100-6

Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-009-2100-6

Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-009-2100-6

Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-009-2100-6

Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-009-2100-6

Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-009-2100-6

Endotoxin/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-009-2100-6

Negative regulation of TLR-signaling pathways by activating transcription factor-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-009-2100-6

Dual ligand stimulation of RAW 264.7 cells uncovers feedback mechanisms that regulate TLR-mediated gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12272-009-2100-6

Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP).

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M312044200

AKT2 inhibition of cisplatin-induced JNK/p38 and Bax activation by phosphorylation of ASK1: implication of AKT2 in chemoresistance.

30 December 2023

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M302674200

Identifiers

DOI

10.1007/S12272-009-2100-6

1 reference

21 August 2017

1 reference

PubMed ID

20091261